How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a cytokine ...
People with Crohn’s disease often take medicines to help manage their condition and improve their symptoms. Some of these medicines are taken by mouth and stay inside of the digestive tract. But ...
Tremfya is the only IL-23 inhibitor with IV and SC induction options for treating Crohn disease. The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults ...
Certolizumab pegol 200 mg/vial; powder for subcutaneous (SC) injection after reconstitution; preservative-free. Elevated levels of TNF-α have been implicated in the pathology of Crohn’s disease.
This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) ...
Several major advances in Crohn's disease have marked 2025, including two new FDA-approved therapies, emerging biologics that target novel pathways, and the first global standards for managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results